Progranulin inhibits expression and release of chemokines CXCL9 and CXCL10 in a TNFR1 dependent manner

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Mundra, Jyoti Joshi ^a   Jian, Jinlong ^b   Bhagat, Priyal ^b   Liu, Chuan Ju ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOURO COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULIN PRECURSOR PROTEIN; RECOMBINANT PROTEIN; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL; CD4+ T LYMPHOCYTE; CLUSTER ANALYSIS; CONTACT DERMATITIS; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MOUSE; PATHOLOGY; SECRETION (PROCESS);

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CLUSTER ANALYSIS; DERMATITIS, CONTACT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS;

EID: 84959016779     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21115     Document Type: Article

References (49)

1. He, Z., Ong, C. H., Halper, J. &Bateman, A. Progranulin is a mediator of the wound response. Nat Med 9, 225-229, doi: 10.1038/nm816 (2003)
2. Bateman, A. &Bennett, H. P. The granulin gene family: from cancer to dementia. Bioessays 31, 1245-1254 (2009)
3. Jian, J., Konopka, J. &Liu, C. Insights into the role of progranulin in immunity, infection, and inflammation. J Leukoc Biol 93, 199-208, doi: 10.1189/jlb.0812429 (2013)
4. Baker, M. et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916-919 (2006)
5. Cruts, M. et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442, 920-924 (2006)
6. Petkau, T. L. &Leavitt, B. R. Progranulin in neurodegenerative disease. Trends in neurosciences 37, 388-398, doi: 10.1016/j. tins.2014.04.003 (2014)
7. Yin, F. et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 207, 117-128, doi: 10.1084/jem.20091568 (2010)
8. Zhu, J. et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111, 867-878 (2002)
9. Kessenbrock, K. et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. The Journal of clinical investigation 118, 2438-2447, doi: 10.1172/JCI34694 (2008)
10. Egashira, Y. et al. The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. J Neuroinflammation 10, 105, doi: 10.1186/1742-2094-10-105 (2013)
11. Kawase, R. et al. Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice. Cardiovasc Res 100, 125-133, doi: 10.1093/cvr/cvt178 (2013)
12. Tang, W. et al. The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice. Science 332, 478-484 (2011)
13. Wei, F. et al. PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner. Scientific reports 4, 7023, doi: 10.1038/srep07023 (2014)
14. Guo, Z. et al. Prevention of LPS-Induced Acute Lung Injury in Mice by Progranulin. Mediators of Inflammation 2012, 10, doi: 10.1155/2012/540794 (2012)
15. Wang, B. C., Liu, H., Talwar, A. &Jian, J. New discovery rarely runs smooth: An update on progranulin/TNFR interactions. Protein &cell 6, 792-803, doi: 10.1007/s13238-015-0213-x (2015)
16. Wei, F., Zhang, Y., Zhao, W., Yu, X. &Liu, C. J. Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions. PloS one 9, e112110, doi: 10.1371/journal.pone.0112110 (2014)
17. Qiu, F. et al. Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus. Diagnostic pathology 8, 88, doi: 10.1186/1746-1596-8-88 (2013)
18. Tanaka, A. et al. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. Arthritis Res Ther 14, R244, doi: 10.1186/ar4087 (2012)
19. Yamamoto, Y. et al. Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis. Inflammation 37, 1806-1813, doi: 10.1007/s10753-014-9911-4 (2014)
20. Miller, Z. A. et al. TDP-43 frontotemporal lobar degeneration and autoimmune disease. Journal of neurology, neurosurgery, and psychiatry 84, 956-962, doi: 10.1136/jnnp-2012-304644 (2013)
21. Johnson, Z. et al. Chemokine inhibition-why, when, where, which and how? Biochemical Society transactions 32, 366-377, doi: 10.1042/(2004)
22. Graves, D. T. &Jiang, Y. Chemokines, a family of chemotactic cytokines. Critical reviews in oral biology and medicine: An official publication of the American Association of Oral Biologists 6, 109-118 (1995)
23. Kotrych, D., Dziedziejko, V., Safranow, K. &Pawlik, A. Lack of association between CXCL9 and CXCL10 gene polymorphisms and the outcome of rheumatoid arthritis treatment with methotrexate. European review for medical and pharmacological sciences 19, 3037-3040 (2015)
24. Kuan, W. P. et al. CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis. The Journal of rheumatology 37, 257-264, doi: 10.3899/jrheum.090769 (2010)
25. Lee, E. Y., Lee, Z. H. &Song, Y. W. The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. Autoimmunity reviews 12, 554-557, doi: 10.1016/j.autrev.2012.10.001 (2013)
26. Ruschpler, P. et al. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis research &therapy 5, R241-252, doi: 10.1186/ar783 (2003)
27. Kwak, H. B. et al. Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis. Arthritis Rheum 58, 1332-1342, doi: 10.1002/art.23372 (2008)
28. Jian, J. et al. Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains. FEBS letters 587, 3428-3436, doi: 10.1016/j.febslet.2013.09.024 (2013)
29. Englen, M. D., Valdez, Y. E., Lehnert, N. M. &Lehnert, B. E. Granulocyte/macrophage colony-stimulating factor is expressed and secreted in cultures of murine L929 cells. Journal of immunological methods 184, 281-283 (1995)
30. Marim, F. M., Silveira, T. N., Lima, D. S., Jr. &Zamboni, D. S. A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PloS one 5, e15263, doi: 10.1371/journal.pone.0015263 (2010)
31. Zhao, Y. P., Tian, Q. Y. &Liu, C. J. Progranulin deficiency exaggerates, whereas progranulin-derived Atsttrin attenuates, severity of dermatitis in mice. FEBS letters 587, 1805-1810, doi: 10.1016/j.febslet.2013.04.037 (2013)
32. Ueno, A. et al. The production of CXCR3-Agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis. Rheumatology international 25, 361-367, doi: 10.1007/s00296-004-0449-x (2005)
33. He, Z. &Bateman, A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. Journal of molecular medicine 81, 600-612, doi: 10.1007/s00109-003-0474-3 (2003)
34. Yasui, K., Oketa, Y., Higashida, K., Fukazawa, H. &Ono, S. Increased progranulin in the skin of amyotrophic lateral sclerosis: An immunohistochemical study. Journal of the neurological sciences 309, 110-114, doi: 10.1016/j.jns.2011.07.003 (2011)
35. Shimada, Y. &Takehara, K. &Sato, S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. Journal of dermatological science 34, 201-208, doi: 10.1016/j.jdermsci.2004.01.001 (2004)
36. Monaco, C., Nanchahal, J., Taylor, P. &Feldmann, M. Anti-TNF therapy: past, present and future. International immunology 27, 55-62, doi: 10.1093/intimm/dxu102 (2015)
37. Bluml, S., Scheinecker, C., Smolen, J. S. &Redlich, K. Targeting TNF receptors in rheumatoid arthritis. International immunology 24, 275-281, doi: 10.1093/intimm/dxs047 (2012)
38. Peschon, J. J. et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. Journal of immunology 160, 943-952 (1998)
39. Higuchi, M. &Aggarwal, B. B. Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation, and differentiation. Journal of immunology 152, 4017-4025 (1994)
40. Lacotte, S., Brun, S., Muller, S. &Dumortier, H. CXCR3, inflammation, and autoimmune diseases. Annals of the New York Academy of Sciences 1173, 310-317, doi: 10.1111/j.1749-6632.2009.04813.x (2009)
41. Antonelli, A. et al. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmunity reviews 13, 272-280, doi: 10.1016/j.autrev.2013.10.010 (2014)
42. Lombardi, A. et al. Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endothelium. European journal of cell biology 88, 731-742, doi: 10.1016/j. ejcb.2009.07.004 (2009)
43. Yellin, M. et al. A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 64, 1730-1739, doi: 10.1002/art.34330 (2012)
44. Cole, K. E. et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187, 2009-2021 (1998)
45. Tensen, C. P. et al. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3) The Journal of investigative dermatology 112, 716-722, doi: 10.1046/j.1523-1747.1999.00581.x (1999)
46. Aggarwal, B. B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 3, 745-756, doi: 10.1038/nri1184 (2003)
47. Tian, Q. et al. Three TNFR-binding domains of PGRN act independently in inhibition of TNF-Alpha binding and activity. Front Biosci (Landmark Ed) 19, 1176-1185 (2014)
48. Li, M. et al. Progranulin is required for proper ER stress response and inhibits ER stress-mediated apoptosis through TNFR2. Cell Signal 26, 1539-1548, doi: 10.1016/j.cellsig.2014.03.026 (2014)
49. Chopra, M. et al. Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis. Carcinogenesis 34, 1296-1303, doi: 10.1093/carcin/bgt038 (2013)